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Abstract
Objective: To provide current global and regional estimates of anaemia pre-
valence and number of persons affected in the total population and by population
subgroup.
Setting and design: We used anaemia prevalence data from the WHO Vitamin and
Mineral Nutrition Information System for 1993–2005 to generate anaemia pre-
valence estimates for countries with data representative at the national level or at
the first administrative level that is below the national level. For countries without
eligible data, we employed regression-based estimates, which used the UN
Human Development Index (HDI) and other health indicators. We combined
country estimates, weighted by their population, to estimate anaemia prevalence
at the global level, by UN Regions and by category of human development.
Results: Survey data covered 48?8% of the global population, 76?1% of preschool-
aged children, 69?0% of pregnant women and 73?5% of non-pregnant women. The
estimated global anaemia prevalence is 24?8% (95% CI 22?9, 26?7%), affecting 1?62
billion people (95% CI 1?50, 1?74 billion). Estimated anaemia prevalence is 47?4%
(95% CI 45?7, 49?1%) in preschool-aged children, 41?8% (95% CI 39?9, 43?8%) in
pregnant women and 30?2% (95% CI 28?7, 31?6%) in non-pregnant women. In
numbers, 293 million (95% CI 282, 303 million) preschool-aged children, 56 million
(95% CI 54, 59 million) pregnant women and 468 million (95% CI 446, 491 million)
non-pregnant women are affected.
Conclusion: Anaemia affects one-quarter of the world’s population and is
concentrated in preschool-aged children and women, making it a global public
health problem. Data on relative contributions of causal factors are lacking,
however, which makes it difficult to effectively address the problem.
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Anaemia, one of the most common and widespread dis-
orders in the world, is a public health problem in both
industrialised and non-industrialised countries. In 2002,
the WHO estimated that anaemia resulting from iron
deficiency was one of the ten most important factors
contributing to the global burden of diseases and that it
increases morbidity and mortality in preschool-aged
children and pregnant women(1). Anaemia is defined as a
decrease in the concentration of circulating red blood
cells or in the haemoglobin concentration and a con-
comitant impaired capacity to transport oxygen. It has
multiple precipitating factors that can occur in isolation
but more frequently co-occur(2). These factors may be
genetic, such as haemoglobinopathies; infectious, such as
malaria, intestinal helminths and chronic infection; or
nutritional, which includes iron deficiency as well as
deficiencies of other vitamins and minerals, such as folate,
vitamins A and B12, and copper
(2).
Because iron deficiency makes a large contribution to
anaemia, global efforts to reduce the anaemia burden
have largely been directed towards increasing intake of
iron through supplementation, food fortification and
diversification of the diet. To assess the iron status of the
population or the response to an intervention to prevent
and control iron deficiency, haemoglobin concentration
has often been used in surveys as a proxy indicator for
iron status under the assumption that anaemia is always
associated with iron deficiency, even if many other
possible causes are present. These surveys have rarely
measured iron deficiency or any of the other factors that
contribute to the development of anaemia and therefore
the contributing factors frequently remain unknown.
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Previous estimates of the prevalence of anaemia in the
world were reported on population subgroups in 1982
and 1992(3,4) and on all population groups in 1985(5) and
2001(6). With the exception of the most recent estimates,
however, which included data up to 1995(6), these reports
did not include data collected after 1990. Moreover, the
1985 report by DeMaeyer and Tegman(5) did not include
data for China, which represents 20 % of the global
population.
The objective of the present paper is to provide current
global and regional estimates of the prevalence of anae-
mia and of the number of persons affected based on
surveys conducted between 1993 and 2005 for the 192
Member States of the WHO. As a result of the vastly
different methodologies used, these estimates are not
quantitatively comparable to previous estimates.
Methods
Data source
We based the current estimates on data available in the
WHO Global Database on Anaemia, a part of the Vitamin
and Mineral Nutrition Information System (VMNIS)
(http://www.who.int/vmnis). This database includes data
on haemoglobin concentration and the prevalence of
anaemia presented by country in a standardised, easily
accessible format.
To establish the WHO Global Database on Anaemia,
we systematically searched and collected data from the
scientific literature (Medline and WHO regional data-
bases) and through a broad network of partners, includ-
ing WHO regional and country offices, UN organisations,
ministries of health, research and academic institutions
and non-governmental organisations. We augmented
these resources by manual searching of articles published
in non-indexed medical and professional journals and
reports from principal investigators.
To include data in the WHO Global Database on
Anaemia, we required a complete original survey report
with details of the sampling method used. In a few
cases, we accepted data provided in writing directly by
ministries of health with detailed methodology, even
without a formal published report. We included
surveys representative of any administrative level and any
population group in the WHO Global Database on
Anaemia if they:
> were population based or facility based (for pregnant
women, newborns, preschool- and school-aged children),
> were cross-sectional or baseline values from an
intervention programme,
> measured haemoglobin concentration from capillary,
venous or cord blood using quantitative photometric
methods or automated cell counters and
> reported the prevalence of anaemia or mean haemo-
globin concentrations.
We excluded surveys that measured only clinical signs
of anaemia or the haematocrit and contacted study
authors for clarification or additional information when
necessary. The administrative level of a survey is national
when the sample is nationally representative, or sub-
national when the sample is representative of a given
administrative level, namely, region, state (first adminis-
trative boundary), district (second administrative bound-
ary) or local. Infrequently, surveys could be national even
though some regions had to be left out for security or
other reasons.
Data selection
For this analysis, we used the following four variables in
selecting data from the WHO Global Database on Anaemia
on haemoglobin concentration and/or the prevalence of
anaemia: the time frame of the survey, the administrative
level for which the survey was representative (national or
subnational), the sample size and the population groups
surveyed.
The time frame for the estimates was from January 1993
to December 2005, and surveys that took place during
this time period and were published by 31 December
2005 were eligible. As of that date, 696 surveys that
reported on data collected between 1993 and 2005 were
available. We used the publication date when the period
of data collection was not specified.
We used data from the most recent national survey in
preference to subnational surveys of more recent vintage.
For one country, where an area had been left out of a
national survey because of security concerns, available
data from the missing region (weighted by the general
population estimate for that area) were pooled with the
national data to provide an estimate for the country. The
estimate was determined by using the most recent census
data from the country. The surveys were conducted
within 1 year of each other and adding the missing region
changed the overall estimate by only 0?1 %. If two
national surveys were conducted in the same year, as was
the case for two population groups from one country, we
pooled the survey results into a single summary measure,
weighted by the sample size of the two surveys. The
difference between the estimates in the two surveys was
5–15 %, depending on the population group. In the
absence of national data, we used surveys that were
representative at the first administrative-level boundary
if two or more surveys at this level were available for
the population group and country concerned within the
acceptable time frame. We pooled the results into a
single summary measure, weighted by the total general
population for that region or state, based on the most
recent and available census data between 1993 and 2005,
without considering the age range covered by the survey.
We did not use local or district-level surveys in these
estimates because they have the potential for more bias.
Worldwide anaemia prevalence 445
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S1368980008002401
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 22:06:45, subject to the Cambridge Core terms of use, available at
As a general rule, we excluded prevalence data based
on a sample of fewer than 100 persons. Given a sample of
100 and a confidence level of 95 %, the error around a
prevalence estimate of 50 % would be 610 percentage
points; a smaller sample would have an even larger error.
A few exceptions were made, however. National surveys
with fewer than 100 but more than fifty participants were
accepted but only where the results were being extra-
polated to fewer than 500 000 people or to pregnant
women.
For this analysis, we defined population subgroups as
follows: preschool children below 5 years, school-aged
children aged 5?00–14?99 years, pregnant women of any
age, non-pregnant women aged 15?00–49?99 years, men
aged 15?00–59?99 years and the elderly, aged 601 years.
Where possible, we excluded children below 0?5 years
from preschool-aged children because an appropriate
haemoglobin cut-off for this age group has not been
determined(6). We did not provide a separate population
estimate for women aged 50?00–59?99 years, as these
women are rarely surveyed. We did, however, include an
estimate for women aged 50?00–59?99 years in our esti-
mate of the global anaemia burden. The methods for
accomplishing this are detailed later. Infrequently, if data
were not disaggregated, we included all women in the
estimate for non-pregnant women even if we did not know
whether pregnant women were included. Where surveys
provided data disaggregated by physiological status, lac-
tating women and non-pregnant women were combined
for the population subgroup non-pregnant women.
We used data disaggregated by the ages that were
closest to the defined age ranges for the population
subgroups. If the age range overlapped two population
subgroups, we placed the survey with the subgroup
where there was a greater overlap in age. When the
age range was unavailable, we used the mean age of
the sample to classify the data. If this was unavailable and
the age range equally spanned two population sub-
groups, we used the population-specific haemoglobin
concentration threshold to classify the data. If data
represented less than 20% of the age range of a population
group, we did not include the survey.
Prevalence of anaemia for countries with
survey data
Normal haemoglobin distributions vary with age, sex and
physiological status, for example, pregnant (varies by
trimester) and non-pregnant(7). We used WHO hae-
moglobin thresholds to classify persons living at sea level
as anaemic: children 0?50–4?99 years and pregnant
women, 110 g/l; children 5?00–11?99 years, 115 g/l; chil-
dren 12?00–14?99 years and non-pregnant women $15?00
years, 120 g/l; men $15?00 years, 130 g/l(6). Statistical
and physiological evidence indicate that haemoglobin
distributions vary with smoking(8) and altitude(9) and,
therefore, we used the prevalence of anaemia corrected for
these factors when provided by the survey. We did not
accept any other corrections. For severe anaemia, we
included surveys that used a haemoglobin cut-off of 70g/l,
which was used by almost all of the surveys that reported
the prevalence of severe anaemia.
For surveys that classified persons by the WHO anae-
mia threshold, we used the reported prevalence data
without any additional calculations. If prevalence was not
reported, or was reported for a different threshold,
we estimated the prevalence using one of the several
methods, all of which assumed a normal distribution
of haemoglobin concentrations. This would slightly
overestimate the prevalence of anaemia in populations
where it is high because population curves of hae-
moglobin concentrations would be skewed to the lower
values. We used the following methods to estimate the
prevalence of anaemia in order of preference:
1. We used the mean and SD of the haemoglobin
concentration to estimate the proportion of persons
falling below the appropriate haemoglobin cut-off for
the population subgroup (n 20). We validated this by
assessing the correlation between the estimated and
predicted prevalence of anaemia in surveys from the
database where a mean, an SD and a prevalence for the
WHO age- and sex-specific cut-off were provided.
This relationship was plotted (n 508), and for most
surveys, the two figures were extremely close
(r25 0?95, P, 0?001) for all four cut-offs (haemo-
globin concentration ,110, 115, 120, 130 g/l). Overall,
predicted prevalence overestimated actual prevalence
by 3?8 percentage points. For 6?5 % of the surveys,
estimated prevalence overestimated actual prevalence
by 10 percentage points or more, and in these surveys
overestimation averaged 16?3 %.
2. When no SD was provided, but prevalence for a non-
WHO cut-off and mean haemoglobin concentration
were available (n 3), we used these two figures to
calculate the SD of the haemoglobin concentration by
assuming a normal distribution within the population
and deriving the Z-score for the prevalence in order
to back-calculate the SD [SD5 (provided cut-off2
mean haemoglobin)/Z-score for given prevalence].
Following this calculation, the mean and SD were
used as above to derive the prevalence for the WHO
cut-off.
3. Finally, for surveys (n 23) that did not present the
mean and SD or the prevalence at the recommended
threshold, we estimated the prevalence of anaemia
from the prevalence at an alternative threshold. We
assumed that an average SD for the same population
subgroup would be close to the actual SD in the survey.
We calculated the mean SD of the haemoglobin
concentration for each population subgroup from
the surveys included in the estimates, which had data
available for participants within the defined age range
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of the population subgroup (mean SD: preschool-aged
children: 13?79 g/l, school-aged children: 11?29 g/l,
non-pregnant women: 13?65 g/l, pregnant women:
14?04g/l, men: 14?53g/l). We estimated the population
mean haemoglobin concentration from the prevalence
at the cut-off provided in the survey and the assumed SD
and created a table to look up the anaemia prevalence
at the recommended threshold.
Severe anaemia is at the lowest end of the haemoglobin
distribution and varies much more than the prevalence of
all anaemia. Thus, we could not use a normal distribution
curve for haemoglobin to estimate prevalence where data
were lacking, and no estimates of the prevalence of
severe anaemia were generated for countries with data
for other haemoglobin thresholds.
Utilising aggregated and disaggregated data for
country estimates
When no disaggregated data were available and the
prevalence of anaemia was reported for school-aged
children using one non-WHO cut-off where two should
have been used, we adjusted the prevalence for the WHO
cut-off that applied to the group in the majority. Similarly,
when two non-WHO cut-offs were used for one group,
we adjusted the prevalence by assuming that the one that
applied to the group in the majority had been used for the
entire group.
In several cases, we combined data provided separately,
such as data for women by physiological status or any
population subgroup disaggregated by age. We combined
the prevalence estimates, weighted by sample size, and if
this information was missing for one of the groups, we
assumed that it had the average number of participants of
the other groups. If information on sample size was missing
from all the data pooled, we gave them equal weight.
95 % Confidence intervals
We considered each estimate of the prevalence of anae-
mia ðp^Þ as representative of the whole country, whether
from national or subnational data. We constructed the
95 % CI in the logit scale (logit transformation of the
estimated prevalence of anaemia) and back-transformed
it to the original scale to provide an interval estimation of
the prevalence. We approximated the estimate of the
variance in the logit scale as va^rðp^Þ ﬃ np^ð1 p^Þ 1,
where p^n is the logit transformation of the estimated
prevalence logðp^=ð1 p^ÞÞ and n is the size of the
sample(10,11). We used a design effect of 2 to compute
the CI because most surveys used for the estimates
employed cluster sampling but did not provide a design
effect. Based on surveys that did provide their design
effect, we considered that 2 was a good estimate of
the typical effect in the surveys used. Finite population
corrections were negligible given the small sampling
fraction in all the countries. In a few country surveys
where sample size was unknown (n 13), we assumed n
was 100.
Estimated prevalence of anaemia for countries
without national or eligible subnational data
For countries without a national or eligible subnational
estimate, we predicted the country’s prevalence of
anaemia from regression equations using the UN Human
Development Index (HDI), which is a composite indi-
cator of a life expectancy index, an education index and a
wealth index(12), and health indicators from the World
Health Statistics database. Separate prediction equations
for each population subgroup were based on countries
with data on the prevalence of anaemia for that subgroup.
We started with the most recent available HDI (2002)
for the regression models because development and
health are most often intertwined. We forced the models
to include HDI and selected the model based on the
adjusted R2 statistic. We solved problems with multi-
collinearity using the variance inflation factor and
removing variables with a value .5. In all population
groups, the models with covariates in addition to HDI
improved the prediction of anaemia. In the elderly, the
covariates added to HDI were not statistically significant,
but the adjusted R2 improved by .40 % (P5 0?198).
For the seventeen countries where the HDI was not
available, we fitted a regression model using two of the
same components and one proxy indicator for education
(average years of schooling in adults instead of adult
literacy and gross enrollment in school) to the group of
countries with HDI estimates and derived an estimated
HDI score(13–15). The percentage of variation explained
by the components was high (96 %). Subsequently, we
used HDI and estimated HDI to predict the prevalence of
anaemia using a multiple regression model. Variables that
we considered for inclusion were general health indica-
tors available for almost all WHO Member States (at least
190) and are listed in Table 1(16).
Table 1 Potential variables for anaemia prediction equations
(WHO Statistics, 2002)
Annual population growth rate (%)
Population in urban areas (%)
Immunization coverage for measles in under-1-year-olds (%)
Immunization coverage for DTP3 in under-1-year-olds (%)
Total expenditure on health (as % of GDP)
General government expenditure on health (as % of total
government expenditure)
Per capita total expenditure on health (in international dollars)
Life expectancy at birth (females)
Life expectancy at birth (males)
Healthy life expectancy at birth (females)
Healthy life expectancy at birth (males)
Adult mortality rate (females)
Adult mortality rate (males)
Under-5 mortality rate
Neonatal mortality
DTP3, diphtheria, tetanus and pertussis; GDP, gross domestic product.
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We performed a diagnostic analysis to assess outliers
and identify observations with a large impact on the
regression coefficients. No more than one outlier was
present in each population subgroup, and the effect
of removing them was negligible. The percentage
of observations with a large impact on the estimated
coefficients was approximately 6–11 %, but it was slightly
higher in the model for school-aged children.
Where only explanatory variables were known, we
estimated the prevalence of anaemia by using the pre-
diction equations (Table 2). For one country, none of the
covariates were available, and thus we did not generate a
country-level estimate.
For severe anaemia, we found that the prevalence was
related to HDI in a curvilinear manner such that the
proportion of severe anaemia was much higher in
countries with low HDI scores, but we did not have
sufficient data to develop a reliable prediction model of
the prevalence of anaemia and so we did not make esti-
mates of the prevalence of severe anaemia for countries
without survey data.
95 % Confidence intervals
We computed point estimates and 95 % prediction inter-
vals for the prevalence of anaemia by using the logit
transformations in the regression models(17) and then
back-transforming them to the original scale(18).
Estimates not used in regression models
After completion of the estimates, we conducted a con-
sultation with each of the WHO Member States to allow
them to review their data before publication. During this
process, it appeared that seven countries had reports that
had been missed for the estimates for one or more
population groups but that were published within the
time frame for the estimates (before December 2005). Of
these, we had used an older estimate for one country and
regression-based estimates for the remaining six. We did
not regenerate the regression models with the new data,
but these seven estimates were replaced. In addition, we
replaced estimates for three countries for one population
group because errors were identified, usually a typing
error in the report. The change in the estimate was 0?1 %
in two cases and 3?8 % in the third. The impact of these
changes on the global and regional estimates was negli-
gible, 0?1 % and ,1?0 %, respectively.
Prevalence of anaemia for all population groups
To estimate the prevalence of anaemia in the entire
population of a nation or an area within a nation, we
pooled the number of people affected in each population
subgroup and divided by the total population to derive
the prevalence. The only segment of the population
missing from these estimates was women aged 50–59
years. For this segment of the population, we applied the
estimate for the elderly, for several reasons. The median T
a
b
le
2
E
q
u
a
tio
n
s
u
s
e
d
to
p
re
d
ic
t
th
e
p
re
v
a
le
n
c
e
o
f
a
n
a
e
m
ia
fo
r
th
e
s
p
e
c
ifi
e
d
p
o
p
u
la
ti
o
n
s
u
b
g
ro
u
p
s
in
c
o
u
n
tr
ie
s
w
it
h
n
o
e
lig
ib
le
s
u
rv
e
y
d
a
ta
P
o
p
u
la
ti
o
n
g
ro
u
p
N
o
.
o
f
c
o
u
n
tr
ie
s
E
q
u
a
tio
n
to
p
re
d
ic
t
a
n
a
e
m
ia
p
re
v
a
le
n
c
e
R
2
P
v
a
lu
e
fo
r
m
o
d
e
l
P
re
s
c
h
o
o
l-
a
g
e
d
c
h
ild
re
n
*
8
2
3
?5
9
7
9
2
4
?9
0
9
3
3
H
D
I2
0
?0
6
5
7
3
E
x
p
o
n
h
e
a
lt
h
2
0
?0
0
0
3
3
E
x
p
o
n
h
e
a
lt
h
p
e
r
c
a
p
it
a
2
0
?0
0
0
9
3
A
d
u
lt
fe
m
a
le
m
o
rt
a
lit
y
0
?5
5
0
,
0
?0
0
0
1
P
re
g
n
a
n
t
w
o
m
e
n
6
0
2
?7
7
8
3
2
2
?8
3
5
2
3
H
D
I2
0
?0
0
8
5
3
Im
m
D
T
P
3
2
0
?0
0
0
4
3
E
xp
o
n
h
e
a
lth
p
e
r
c
a
p
ita
2
0
?0
0
1
7
3
A
d
u
lt
M
a
le
m
o
rt
a
lit
y
0
?3
2
3
,
0
?0
0
0
1
N
o
n
-p
re
g
n
a
n
t
w
o
m
e
n
7
9
0
?9
4
7
5
2
2
?3
4
4
7
3
H
D
I1
0
?1
6
4
3
3
P
o
p
u
la
tio
n
g
ro
w
th
ra
te
2
0
?0
6
9
7
3
E
x
p
o
n
h
e
a
lt
h
0
?4
5
3
,
0
?0
0
0
1
S
ch
o
o
l-
a
g
e
d
c
h
ild
re
n
3
5
1
?4
2
4
8
2
2
?6
8
9
4
3
H
D
I1
0
?0
0
8
7
3
U
rb
a
n
p
o
p
u
la
ti
o
n
2
0
?0
1
2
9
3
Im
m
m
e
a
s
le
s
2
0
?0
0
0
5
3
E
x
p
o
n
h
e
a
lth
p
e
r
c
a
p
ita
0
?5
8
3
,
0
?0
0
0
1
M
e
n
3
2
0
?0
9
9
1
2
4
?6
1
6
0
3
H
D
I1
0
?0
2
0
9
3
Im
m
D
T
P
3
2
0
?0
8
2
8
3
G
o
v
e
x
p
o
n
h
e
a
lth
0
?5
7
7
,
0
?0
0
0
1
E
ld
e
rl
y
1
3
2
1
?6
6
9
3
1
0
?2
8
7
2
3
H
D
I2
0
?1
3
5
9
3
E
x
p
o
n
h
e
a
lt
h
1
0
?0
0
4
7
3
A
d
u
lt
m
a
le
m
o
rt
a
lit
y
0
?3
8
5
0
?0
6
2
7
H
D
I,
U
n
it
e
d
N
a
ti
o
n
s
H
u
m
a
n
D
e
v
e
lo
p
m
e
n
t
In
d
e
x
;
E
x
p
,
e
x
p
e
n
d
it
u
re
;
Im
m
D
T
P
3
,
im
m
u
n
iz
a
ti
o
n
fo
r
d
ip
h
th
e
ri
a
,
te
ta
n
u
s
a
n
d
p
e
rt
u
s
s
is
.
*P
o
p
u
la
ti
o
n
s
u
b
g
ro
u
p
s
:
P
re
s
c
h
o
o
l-
a
g
e
d
c
h
ild
re
n
(0
?0
0
–
4
?9
9
y
e
a
rs
),
P
re
g
n
a
n
t
w
o
m
e
n
,
N
o
n
-p
re
g
n
a
n
t
w
o
m
e
n
(1
5
?0
0
–
4
9
?9
9
y
e
a
rs
),
S
c
h
o
o
l-
a
g
e
d
c
h
ild
re
n
(5
?0
0
–
1
4
?9
9
y
e
a
rs
),
M
e
n
(1
5
?0
0
–
5
9
?9
9
y
e
a
rs
),
E
ld
e
rl
y
($
6
0
?0
0
y
e
a
rs
).
448 E McLean et al.
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S1368980008002401
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 22:06:45, subject to the Cambridge Core terms of use, available at
age of menopause in women is approximately 50?5
years(19), suggesting that for the majority of women in this
age group, losses of iron from menstruation have stop-
ped. Further, the data from the National Health and
Nutrition Examination Survey (NHANES) in the United
States were compared by one of the authors of the paper
(M.C.) between women aged 20–49 years, 50–59 years
and 601 years, and women aged 50–59 years had a
haemoglobin distribution that was more similar to women
aged 601 years than to those aged 20–49 years. In
addition, the distribution of C-reactive protein (CRP) was
more similar between women aged 50–59 years and 601
years. The proportion of anaemia attributable to elevated
CRP in women aged 50–59 years was more similar to
those aged 20–49 years.
Combining national estimates
For each population subgroup, we combined prevalence
for countries grouped by geographical location or level of
development, based on HDI, using a weighted average of
the estimates for the countries. Weights were proportional
to the number of persons in the population subgroup in
each country. We derived confidence limits for combined
prevalence estimates for the countries by using the esti-
mated variance of a weighted average. We calculated the
number of persons suffering from anaemia in a given
population subgroup by multiplying the estimated pre-
valence (point and confidence limits) in the subgroup by
the total population in that subgroup.
For one country, the indicators used for the regression-
based estimates were not available, and so we did not
generate an estimate for that country. Thus, for regional,
global and development group estimates, we applied the
estimate for this country’s UN subregion, which was well
covered by survey data.
Anaemia by category of development
We classified countries by category of development, using
the standard UN groupings, based on the HDI: high
(HDI. 0?800), medium (0?500$HDI#0?800) and low
(HDI, 0?500). For the seventeen countries with no offi-
cial HDI score, we used their regression-based estimate of
HDI to classify them.
Population coverage, proportion of population
and the number of persons with anaemia
Population coverage
We produced estimates only for WHO Member States, but
these countries together represent 99?8 % of the global
population. The population covered by survey data for
a given grouping of countries (global, grouped by UN
region or level of development) was calculated for each
grouping as the sum of the number of persons in the
population subgroup in countries with survey data divi-
ded by the total number of persons in the population
subgroup in the WHO Member States of the specific
grouping. Coverage when including countries with a
regression-based ‘proxy’ estimate is not presented
because it was similar for all population subgroups and
included all countries except for one (99?7–99?9 % of the
WHO member state population depending on the
population subgroup).
Proportion of population and the number of
people with anaemia
We estimated the number of people with anaemia in each
population subgroup for each country and each grouping
of countries based on each country’s proportion of the
population with anaemia. We multiplied the proportion
of the population subgroup with anaemia by its national
population to determine the number of persons with
anaemia at the country level and provided the 95 % CI as
a measure of uncertainty. The population figures are for
the 2006 projection from the 2004 revision of the UN
population estimates(20). We derived population figures
for pregnant women from the total number of births (time
period 2005–10) by assuming one child per woman per
year, not taking into account spontaneous and induced
abortions. For fifteen countries with a small total popu-
lation (they represented 0?01 % of all women), birth data
were not provided in tabulations of the UN population
division, and here we estimated the number of pregnant
women by applying a WHO regional average of births per
reproductive-age woman (15?00–49?99 years) to the total
number of reproductive-age women.
Results
Coverage
All countries, except for one, were covered by actual data
or by regression-based estimates. Data from national or
subnational surveys covered almost three-quarters of the
global population of preschool-aged children and non-
pregnant women and almost 70 % of the population of
pregnant women but less than half of the populations
of school-aged children, men and the elderly (Table 3).
Only the estimates for preschool-aged children included
subnational estimates (three countries, 1?9 % of the
population), but national estimates still covered more
than 70 % of this population. Because of the low coverage
for school-aged children, men and the elderly throughout
the world, estimates on the prevalence of anaemia for the
entire population were generated at the global level and
by the level of development, but not by country. The
global estimate of anaemia is based on coverage from
national and eligible subnational surveys of almost half of
the world’s population.
Prevalence of anaemia
The global figures and number of persons affected
are displayed in Fig. 1 for each population subgroup.
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The global prevalence of anaemia is 24?8 % (95 % CI 22?9,
26?7 %), and 1?62 billion people (95 % CI 1?50, 1?74
billion) are affected. In numbers, non-pregnant women
are the most affected (468?4 million, 95 % CI 446?2,
490?6), but the highest prevalence is in preschool-aged
children (47?4 %, 95 % CI 45?7, 49?1 %).
For preschool-aged children, non-pregnant and preg-
nant women, estimates by UN regions are presented in
Table 4. Africa has the highest prevalence of anaemia for
all three population groups, but the greatest number of
people affected are in Asia, where 58?0 %, 56?1 % and
68?0 % of the anaemia burden in preschool-aged children,
pregnant women and non-pregnant women, respectively,
exists. The majority of these people live in south-central
Asia (data not shown).
When the countries are considered by category of
development, the prevalence of anaemia decreases from
the low to the high category, but the majority of those
affected by anaemia live in countries in the medium-
development category because these countries account
for 68?2 % of the global population, while the countries
classified in the low- and high-development categories
account for only 13?1 % and 18?6 % of the global
population, respectively. On a global scale, 9?1 %, 25?7 %
and 42?8 % of the population in countries in the high-,
medium- and low-development categories are affected,
respectively, resulting in 111 million (95 % CI 102, 120
million), 1?1 billion (95 % CI 1?0, 1?3 billion) and 367
million (95 % CI 336, 398 million) people in these
groups suffering from anaemia. The prevalence of anae-
mia and the incremental burden of anaemia by human
development category are displayed for each of the
population subgroups and the entire population in Fig. 2.
For preschool-aged children, data on the prevalence of
severe anaemia covered 38?5% of the population and less
than 50% of the population in all regions except North
America, which had only one country with data, and the
estimates were unreliable. In pregnant women, the data on
severe anaemia are even fewer, with only 14?1% of the
global population of pregnant women covered by such
data. Therefore, separate estimates for severe anaemia in
these two subgroups of concern could not be made. In the
Table 3 Percentage of population covered and number of countries with anaemia survey data
Category PreSAC* NPW PW SAC Men Elderly All
Global (192)- 76?1 (84)-
-
73?5 (82) 69?0 (64) 33?0 (36) 40?2 (34) 39?1 (13) 48?8
UN regiony
Africa (53) 76?7 (30) 63?6 (26) 65?3 (25) 18?6 (10) 32?0 (14) 1?8 (1) 40?7
Asia (47) 82?1 (30) 88?8 (34) 80?9 (21) 37?0 (11) 47?6 (13) 54?1 (7) 58?0
Europe (41) 19?2 (5) 23?9 (5) 0?9 (1) 12?9 (3) 15?9 (2) 8?7 (2) 14?9
L. America and the Caribbean (33) 70?5 (15) 37?5 (12) 38?4 (14) 28?9 (8) 0?1 (1) 0?0 (0) 22?9
N. America (2) 92?4 (1) 89?9 (1) 92?8 (1) 91?3 (1) 89?9 (1) 89?6 (1) 84?3
Oceania (16) 5?1 (3) 16?5 (4) 4?7 (2) 15?1 (3) 15?6 (3) 15?1 (2) 13?8
Level of development||
High (59) 50?5 (8) 59?3 (12) 15?1 (4) 51?3 (11) 50?0 (10) 46?2 (7) 48?8
Medium (94) 80?5 (51) 76?5 (46) 73?2 (36) 36?4 (19) 40?6 (14) 39?1 (6) 51?0
Low (39) 67?9 (23) 68?1 (21) 58?0 (20) 7?1 (5) 18?4 (8) 0?0 (0) 37?6
*Population subgroups: PreSAC, preschool-aged children (0?00–4?99 years); NPW, non-pregnant women (15?00–49?99 years); PW, pregnant women; SAC,
school-aged children (5?00–14?99 years); Men (15?00–59?99 years); Elderly ($60?00 years)
-Number of countries in each grouping.
-
-
Total number of countries with data, no figure is provided for All since each country may be partially covered by some population groups, but few countries
have data on all six population groups and no countries have data for 50–59-year-old women.
yUN regions: Africa, Asia, Europe, Latin America and the Caribbean (LAC), Northern America (NA), Oceania.
||Level of development as classified by the UN Human Development Index (HDI): high (HDI score: .0?800), medium (HDI score: 0?500–0?800), low (HDI
score: ,0?500).
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PreSAC, 293.1
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SAC, 304.6
Men, 259.6
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Total: 1621.2 (95 % Cl 1497.4, 1745.0)
Fig. 1 (a) Global prevalence of anaemia (%) and (b) number of
individuals (millions) affected in different population groups
(population subgroups: PreSAC, preschool-aged children
(0?00–4?99 years); PW, pregnant women; NPW, non-pregnant
women (15?00–49?99 years); SAC, school-aged children
(5?00–14?99 years); Men (15?00–59?99 years); Elderly
($60?00 years); the number of individuals affected includes a
figure for women aged 50?00–59?00 years, which is based on
the estimate of anaemia prevalence in the elderly)
450 E McLean et al.
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S1368980008002401
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 22:06:45, subject to the Cambridge Core terms of use, available at
countries with data for preschool-aged children, severe
anaemia averages 5?9% as a proportion of all anaemia, but
this figure ranges from an average of 2?0% in the four
countries with data in Latin America and the Caribbean to
an average of 8?8% in the seventeen countries covered in
Africa. By country, prevalence ranges from 0?4% in one
country in Asia to 20?4% in a country in Africa.
Discussion
These estimates represent the most recent and accurate
data available on the worldwide prevalence of anaemia.
We found that between 1993 and 2005, anaemia affected
one in four persons globally: pregnant women and young
children are at greatest risk. Geographically, people living
in Asia and Africa are at greatest risk: almost two-thirds of
preschool-aged children living in Africa are anaemic.
Assessing global progress is difficult because the
methodologies used for these and previous estimates vary
significantly. We believe, however, that our estimates
include three major improvements. First, our global esti-
mate includes nationally representative data for China,
which accounts for 20 % of the global population; the
earlier global estimate of anaemia did not include
China(5).
Second, in the past, few nationally representative
surveys were available, and the estimates were based
primarily on data from regional, state and local surveys.
Clearly, national surveys more accurately represent the
total population, especially as regional, state and local
surveys may be conducted in locations with an unusually
low or high prevalence of anaemia. In some instances,
survey locations are chosen because of a particular con-
cern about a health condition or economic change, and
thus the findings may overestimate the prevalence of
anaemia for the entire country. At other times, areas may
be selected because of accessibility, and they may be
better off economically than remote areas of a country.
The use of national surveys should help eliminate bias in
either direction. For our estimates, we used almost all
nationally representative surveys, and the percentage
of the population covered by these surveys remained
high for preschool-aged children, pregnant women and
non-pregnant women.
Finally, we used regression estimates for countries
without data from eligible surveys; we found that a sub-
stantial proportion of the variation in anaemia within a
Table 4 Anaemia in preschool-aged children, non-pregnant women and pregnant women
Pre-SAC- NPW PW
UN region* Prevalence (%) No. affected Prevalence (%) No. affected Prevalence (%) No. affected
Africa 64?6 (61?7, 67?5)-
-
93?2 (89?1, 97?4) 44?4 (40?9, 47?8) 82?9 (76?5, 89?4) 55?8 (51?9, 59?6) 19?3 (18?0, 20?7)
Asia 47?7 (45?2, 50?3) 170?0 (161?0, 178?9) 33?0 (31?3, 34?7) 318?3 (302?0, 334?6) 41?6 (39?0, 44?2) 31?7 (29?7, 33?6)
Europe 16?7 (10?5, 23?0) 6?1 (3?8, 8?4) 15?2 (10?5, 19?9) 26?6 (18?4, 34?9) 18?7 (12?3, 25?1) 1?4 (0?9, 1?8)
LAC 39?5 (36?0, 43?0) 22?3 (20?3, 24?3) 23?5 (15?9, 31?0) 33?0 (22?4, 43?6) 31?1 (21?8, 40?4) 3?6 (2?5, 4?7)
NA 3?4 (2?0, 4?9) 0?8 (0?4, 1?1) 7?6 (5?9, 9?4) 6?0 (4?6, 7?3) 6?1 (3?4, 8?8) 0?3 (0?2, 0?4)
Oceania 28?0 (15?8, 40?2) 0?7 (0?4, 1?0) 20?2 (9?5, 30?9) 1?5 (0?7, 2?4) 30?4 (17?0, 43?9) 0?2 (0?1, 0?2)
*UN regions: Africa, Asia, Europe, Latin America and the Caribbean (LAC), Northern America (NA) and Oceania.
-Population subgroups: Pre-SAC, preschool-aged children (0?00–4?99 years); NPW, non-pregnant women (15?00–49?99 years); PW, pregnant women.
-
-
95% confidence interval.
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Fig. 2 Prevalence of anaemia by categories of development (UN Human Development Index groupings of countries by category of
development: , High (HDI.0?800); , Medium (0?500#HDI#0?800); , Low (HDI,0?500)) for population subgroups and all
individuals (population subgroups: PreSAC, preschool-aged children (0?00–4?99 years); PW, pregnant women; NPW, non-
pregnant women (15?00–49?99 years); SAC, school-aged children (5?00–14?99 years); Men (15?00–59?99 years); Elderly ($60?00
years); All includes preceding population groups and women aged 50?00–59?99 years))
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population subgroup was explained by the economic and
health indicators of the countries used for the regression
analysis (32–55 %). Previous estimates of anaemia for
countries with missing data used information from
neighbouring countries or applied the anaemia estimate
from all countries with data to those without data for the
specified population subgroup. If we made the latter
assumption, our prevalence estimates would have been
slightly higher in preschool-aged children, non-pregnant
and pregnant women (1?2–2?3 percentage points), and
somewhat lower in school-aged children, men and the
elderly (1?9–8?5 percentage points), where there are
fewer data. In comparison with our estimate of 25%,
DeMaeyer estimated that 30% of the world’s population
was anaemic around 1980 (1960–85). The methods used to
derive DeMaeyer’s global estimate are unclear, although it
seems to be based on an extrapolation of the estimates for
preschool-aged children, school-aged children, men and
women. By subgroup, DeMaeyer’s estimates (which exclu-
ded China) were 43% for preschool-aged children, 35% for
all women and 51% in pregnant women. If we exclude
China from our estimates, our corresponding estimates are
52%, 34% and 44%. As stated above, variation in methods
and our larger number of nationally representative data may
explain the difference in the estimates, rather than an actual
change in anaemia status.
In 1992, WHO published global prevalence figures for
1988 of 37 %, 51 % and 35 % for all women, pregnant
women and non-pregnant women, respectively. These
estimates include subnational data for China. Again, the
current estimates of 31 %, 42 % and 30 % may not be
different when the substantial difference in methods
is considered.
Our estimates are subject to limitations. First, because
surveys less frequently include data on school-aged
children, men and the elderly, in some regions the
number of countries with data on these population
groups was limited or non-existent. Therefore, we pre-
sent only global estimates for these groups, but even
these estimates should be interpreted with some caution.
Second, many assumptions had to be made to derive
our global estimates. All surveys were treated equally, but
in actuality surveys vary greatly in quality in their selec-
tion of samples, presence or absence of adjustment for
smoking and altitude, and numerous other factors. Some
estimates covered only a portion ($20 %) of the popu-
lation subgroup, which may have resulted in an artificially
high or low estimate being applied to that population
subgroup, as some surveys of preschool-aged children
focus on younger children, who have a higher prevalence
of anaemia, while others focus on older children. For only
three countries, subnational data representative of at least
two first administrative-level divisions were treated simi-
larly to national data, because data covering a substantial
segment of the population for a country were preferable
to proxy estimates. Even so, because the surveys are not
nationally representative, they may underestimate or
overestimate the actual anaemia prevalence, as described
previously.
For some countries we calculated prevalence using
assumptions about the distribution of haemoglobin
concentration because the prevalence of anaemia was
not reported using the appropriate threshold for this
concentration. Overall, this may have led to a slight
overestimation of prevalence, because haemoglobin was
assumed to be normally distributed for these calculations
even though it is not.
A design effect of 2 was applied to all surveys because
in the few surveys that provided a design effect, the
average size was 1?6–1?8. However, individual surveys
may have had design effects larger or smaller than this
figure. This may have resulted in narrower or wider CI for
the regional and global estimates.
The estimates based on grouping by HDI development
are based on prevalence estimates for countries, some of
which used regression equations that were based on HDI;
this is a limitation of these estimates. The coverage of these
groups by actual data, however, was high for preschool-
aged children and non-pregnant women as well as for
pregnant women in the low and medium categories of
development, and they do provide useful information. For
example, it is notable that there is more than a fivefold
increase in anaemia prevalence in preschool-aged children
from the high to low category of development, and this is
based on a substantial amount of actual prevalence data.
Also of interest is that, for the high category of development,
prevalence in the elderly is similar to that of preschool-aged
children or non-pregnant women, with comparable survey
coverage. This may indicate that prevalence in the elderly
for the other categories of development, where survey
coverage is poor, is underestimated.
Finally, the estimates for pregnant women do not take
into account the trimester at the time of assessment.
Women in the first trimester may have a lower risk of
anaemia than non-pregnant women because menstrua-
tion has stopped and the increases in blood cell volume
and the growth of the fetus and placental tissues are
minimal. In the second and third trimester, however,
increases in fetal growth and expansion in red blood cell
mass increase the risk of anaemia v. that borne by non-
pregnant women. Thus, variation in the gestational age at
the time of measurement may account for differences in
prevalence estimates by country. For example, if a sub-
stantial proportion of women were assessed in their first
trimester, the prevalence of anaemia among pregnant
women may be lower than that among non-pregnant
women. Another possible reason for variations in the
prevalence of anaemia among pregnant women may be
variation in consumption of supplements of multivitamins
or minerals. In some countries, pregnant women may be
more likely than non-pregnant women to consume these
supplements(21).
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Anaemia results from the interaction of several causal
factors that may vary from one population to another.
Clearly, knowledge of the cause of anaemia is required to
fully interpret data on prevalence and to design appro-
priate interventions to reduce it. Only a few surveys
looked at causation, and the ones that did focused on iron
deficiency. Even so, there are few data available on iron
status, which makes it difficult to generate estimates of
iron deficiency or of iron deficiency anaemia. We know,
however, that anaemia may reflect iron status where iron
deficiency is its main cause and therefore may be used
appropriately as a proxy indicator. For instance, data from
some countries, like the USA, where the prevalence of
anaemia is extremely low (3?1–6?9 %) suggest that it
reflects the impact of the increased consumption of iron
due to iron fortification of commercial foods as they
contribute 20–25 % to the total iron intake(22).
In conclusion, the data available now are more plen-
tiful and more representative than they were for any of
the previous estimates, and thus we may have the most
accurate picture to date of the prevalence of anaemia.
Still, countries without data should be encouraged to
survey their population in order to have a more accurate
picture of prevalence and should also be encouraged to
include assessment of helminth infection, malaria and
iron status to better understand the aetiology of anaemia
within their country. These estimates of prevalence are
valuable because they allow the comparison of anaemia
status among countries in high-risk groups and permit
tracking of the progress of various countries in eliminat-
ing this scourge. They also provide useful information to
assess how effective the current strategies are to control
anaemia, but this information needs to be interpreted
with caution. Indeed, the majority of the available surveys
did not collect data on primary causes, so that their use-
fulness for deciding on the most effective strategies to
combat anaemia is limited. Ideally, these estimates will
draw the attention of the public health community to the
need to assess the prevalence of factors that contribute to
the development of anaemia, not only iron deficiency,
but also parasitic and infectious diseases, and to deter-
mine how these causes vary by geography, level of
development and other social and economic factors. This
will make it easier to design more effective interventions
that integrate and take into account all of these factors.
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